The Alfred Hospital

Impact of Antihypertensive Medication Changes after Renal Denervation among Different Patient Groups: SPYRAL HTN-ON MED (2024) Townsend RR, Ferdinand KC, Kandzari DE, Kario K, Mahfoud F, Weber MA, Schmieder R, et al. Journal article Interleukin-13 and its receptor are synaptic proteins involved in plasticity and neuroprotection (2023) Li S, olde Heuvel F, Rehman R, Aousji O, Froehlich A, Li Z, Jark R, et al. Journal article Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022) Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, Dunning AM, et al. Journal article Global Characterisation of Coagulopathy in Isolated Traumatic Brain Injury (iTBI): A CENTER-TBI Analysis (2021) Boehm JK, Gueting H, Thorn S, Schaefer N, Rambach V, Schoechl H, Grottke O, et al. Journal article Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation (2021) Mahfoud F, Townsend RR, Kandzari DE, Kario K, Schmieder R, Tsioufis K, Pocock S, et al. Journal article Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2021) Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, et al. Journal article Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women (2021) Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, et al. Journal article Extended Coagulation Profiling in Isolated Traumatic Brain Injury: A CENTER-TBI Analysis (2021) Boehm JK, Schaeben V, Schaefer N, Gueting H, Lefering R, Thorn S, Schoechl H, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. (2021) Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, et al. Journal article